Related Experiment Video
Updated: May 10, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
When East Meets West: Cross-Domain Drug Interaction Annotations With Large Language Models and Bidirectional Neural
Abstract:
Drug combination therapy is a promising strategy for managing complex and co-existing diseases. However, drug-drug interactions (DDIs) can result in unexpected adverse effects, making it crucial to understand such interactions to prevent adverse drug reactions and develop new therapeutic strategies. Current DDI annotation methods heavily rely on atom-level graph structural features, overlooking valuable drug contextual representations within medical literature. Additionally, these methods are typically designed for a specific task, limiting their scalability to diverse medical scenarios. To address these limitations, we propose TEmbed-DDI, a novel framework that leverages contextual representations and pre-trained large language model embeddings to enhance feature extraction for DDI annotations. Specifically, we retrieve meaningful contextual texts for each drug to enrich semantic features and adopt pre-trained large language model embeddings to capture rich features from these long-range contextual representations. TEmbed-DDI is the first framework to incorporate LLM-powered embeddings for medical interaction annotations. Furthermore, a bidirectional neural network is integrated into TEmbed-DDI for the integrative Western and traditional Chinese medicine DDI annotation tasks. Comparative results demonstrate that TEmbed-DDI achieves state-of-the-art performance, with the highest AUC scores of 0.992 and 0.95 on the Western CHCH and DEEP interaction annotation benchmarks. Even for the newly constructed Traditional Chinese Medicine (TCM) DDI annotation benchmark, TEmbed-DDI consistently exhibits outstanding generalization capability, achieving an AUC of 0.956. Moreover, case studies further validate TEmbed-DDI's capability to annotate previously unknown interactions. These findings suggest that TEmbed-DDI can serve as a valuable tool in annotating previously unknown drug combinations for real-world applications, facilitating the development of efficacious therapies. Furthermore, as the first framework combining traditional Chinese medicine into DDI annotation tasks, its adaptability highlights the potential in supporting cross-domain medical research. TEmbed-DDI's design principles can inspire the development of flexible LLM-powered frameworks for drug combination discovery in the future.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Drug Biotransformation: Overview
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...

